Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 4-(4Methoxybenzyl)-n′-(5-nitro1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3 (gsk3)

4-(4Methoxybenzyl)-n′-(5-nitro1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3 (gsk3)

US Patent 7056939 · Granted Jun 6, 2006

Estimated economic value: $12,341,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Process and apparatus for oxidizing organic compounds2013
Compounds2010
3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (G2010
3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (G2010
Compounds having selective inhibiting effect at GSK32009
Compounds having selective inhibiting effect at GSK32009
Compounds having selective inhibiting effect at GSK32009
Compounds having selective inhibiting effect at GSK32009
Compounds having selective inhibiting effect at GSK32009
Compounds having selective inhibiting effect at GSK32009
Substituted indan derivatives2008
3-Heterocyclyl-indole inhibitors of glycogen synthase kinase-32008